GILD
Gilead Sciences Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Gilead Sciences, Inc. is a leading biopharmaceutical company based in Foster City, California, renowned for its pioneering advancements in antiviral therapeutics, especially for HIV and hepatitis. The company's innovative treatments, such as Harvoni and Sovaldi, have fundamentally transformed the ma...
$125.59
-0.22% ($0.28)
Volume
5.21M
52W High
$157.29
52W Low
$103.05
Market Cap
$167.80B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$6.62
Whisper EPS
-$6.62
0.0% below consensus
Last Quarter
$2.03
Current Streak
8 Beats
Avg Surprise (4Q)
+15.06%
Next Earnings Report
Reports in 52 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 7, 2026
1-Day:
-2.04%
5-Day:
+0.66%
Q1 2026
Apr 23, 2026
1-Day:
-2.42%
5-Day:
-3.28%
Q4 2025
Feb 10, 2026
1-Day:
+5.82%
Q3 2025
Oct 30, 2025
1-Day:
+1.14%
5-Day:
+3.85%
Revenue & Financial Performance
Revenue Whisper
$7.02B
TWN Proprietary Estimate
Last Quarter Revenue
$6.96B
+4.4% YoY
Gross Margin
79.2%
Net Margin: 29.0%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $6.96B | +4.4% | 79.2% | 38.7% | $2.02B |
| Q4'25 | $7.92B | +4.7% | 79.5% | 37.7% | $2.18B |
| Q3'25 | $7.77B | +3.0% | 79.8% | 42.8% | $3.05B |
| Q2'25 | $7.08B | +1.8% | 78.8% | 34.9% | $1.96B |
| Q1'25 | $6.67B | -0.3% | 76.9% | 33.6% | $1.32B |
| Q4'24 | $7.57B | +6.4% | 79.1% | 32.4% | $1.78B |
| Q3'24 | $7.55B | +7.0% | 79.1% | 11.8% | $1.25B |
| Q2'24 | $6.95B | +5.4% | 77.8% | 38.0% | $1.61B |
Company Information
Symbol
GILD
Company
Gilead Sciences Inc
Market Cap
$167.80B
Sector
HEALTHCARE
Next Earnings
Aug 6, 2026
Also Reporting Soon
Companies reporting earnings around the same time as GILD
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare GILD with competitors
Side-by-side earnings comparison